💨 Abstract

The Indian Pharmaceutical Alliance (IPA) has refuted a study by Ohio State University researchers, linking Indian generic drugs to higher severe adverse events. The IPA calls the study "ill-researched" and insists that Indian generic drugs comply with global regulatory standards. They argue that the study's findings are based on FAERS data, which has limitations and does not prove causation.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖